Winston Medical Supply Co., Ltd. (TPEX:6817)

Market Cap	1.11B -46.3%
Revenue (ttm)	700.07M +0.7%
Net Income	117.29M -10.9%
EPS	6.35 -10.8%
Shares Out	18.42M
PE Ratio	9.46
Forward PE	n/a
Dividend	5.00 (8.46%)
Ex-Dividend Date	Jun 16, 2026

Volume	1,093
Open	60.10
Previous Close	59.10
Day's Range	59.50 - 60.10
52-Week Range	57.10 - 116.50
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Winston Medical Supply

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally. The company offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations that are in oral dosage forms, such as powders, troches, tablets, film coated tablets, che...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1974
• Employees: 180
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6817

Financial Performance

In 2025, Winston Medical Supply's revenue was 700.07 million, an increase of 0.72% compared to the previous year's 695.08 million. Earnings were 117.29 million, a decrease of -10.87%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 9, 2026

Data Sources Report a data error